STRATIFY; Near-infrared fluorescence molecular imaging of adalimumab-800CW to elucidate the drug distribution throughout inflamed tissue in inflammatory bowel disease and rheumatoid arthritis
Phase 1 other active
Quick answer
STRATIFY; Near-infrared fluorescence molecular imaging of adalimumab-800CW to elucidate the drug distribution throughout inflamed tissue in inflammatory bowel disease and rheumatoid arthritis for Crohn's disease, Spondyloarthritis, Rheumatoid arthritis, Ulcerative colitis is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Crohn's disease, Spondyloarthritis, Rheumatoid arthritis, Ulcerative colitis
- Phase
- Phase 1
- Modality
- other
- Status
- active